To determine whether CXCR5+PD‐1+ CD8 T cells play a similar role in response to PD‐1 ICB in the human setting, we studied these cells in healthy individuals and in patients with hematologic malignancies with varying response rates to PD‐1 ICB. The gene discussed is CXCR5; the disease is hematologic disorder.